ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)

China · Delayed Price · Currency is CNY

38.90

+0.19 (0.49%)

May 19, 2026, 4:00 PM EDT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Specialty Chemicals		333.13M	414.30M	411.46M	415.73M	373.04M
Specialty Chemicals Growth		-19.59%	0.69%	-1.03%	11.44%	26.89%
Total		333.13M	414.30M	411.46M	415.73M	373.04M
Total Growth		-19.59%	0.69%	-1.03%	11.44%	26.89%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China		223.50M	264.94M	205.85M	194.96M	244.93M
China Growth		-15.64%	28.70%	5.59%	-20.40%	-
Foreign		109.63M	149.37M	205.61M	220.76M	128.04M
Foreign Growth		-26.60%	-27.35%	-6.86%	72.42%	-
Total		333.13M	414.30M	411.46M	415.73M	372.96M
Total Growth		-19.59%	0.69%	-1.03%	11.47%	-

Source: S&P Global Market Intelligence.